Breaking Barriers in the Genomics and Pharmacogenetics of Drug Addiction

Pharmacogenetics of Drug Dependence: Role of Gene Variations in Susceptibility and Treatment

(2010) Jibran Y. Khokhar et al.   Annual Review of Pharmacology and Toxicology

Modeling of Environmental Effects in Genome-Wide Association Studies Identifies SLC2A2 and HP as Novel Loci Influencing Serum Cholesterol Levels

(2010) Wilmar Igl et al.   PLoS Genetics

Gene-environment interactions and alcohol use and dependence: current status and future challenges

(2009) Carmen S. van der Zwaluw et al.   ADDICTION

Differential Allelic Expression of Dopamine D1 Receptor Gene (DRD1) Is Modulated by microRNA miR-504

(2009) Weihua Huang et al.   BIOLOGICAL PSYCHIATRY

The Neurobiology of Addictive Disorders

(2009) Stephen Ross et al.   CLINICAL NEUROPHARMACOLOGY

How Will GINA Influence Participation in Pharmacogenomics Research and Clinical Testing?

(2009) L G Dressler et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Opiate and cocaine addiction: from bench to clinic and back to the bench

(2009) Mary Jeanne Kreek et al.   CURRENT OPINION IN PHARMACOLOGY

Association of serum cotinine level with a cluster of three nicotinic acetylcholine receptor genes (CHRNA3/CHRNA5/CHRNB4) on chromosome 15

(2009) Kaisu Keskitalo et al.   HUMAN MOLECULAR GENETICS

Genome-wide Association Studies and Human Disease

(2009) Peter M. Visscher et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

New insights into the genetics of addiction

(2009) Ming D. Li et al.   NATURE REVIEWS GENETICS

Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution

(2009) Alexandra Doehring et al.   Pharmacogenetics and Genomics

Rare Variants of IFIH1, a Gene Implicated in Antiviral Responses, Protect Against Type 1 Diabetes

(2009) S. Nejentsev et al.   SCIENCE

Convergence of genetic findings for nicotine dependence and smoking related diseases with chromosome 15q24-25

(2009) Laura Jean Bierut   TRENDS IN PHARMACOLOGICAL SCIENCES

The Alcohol Flushing Response: An Unrecognized Risk Factor for Esophageal Cancer from Alcohol Consumption

(2009) Philip J Brooks et al.   PLOS MEDICINE

Are there genetic influences on addiction: evidence from family, adoption and twin studies

(2008) Arpana Agrawal et al.   ADDICTION

Differential Neural Response to Alcohol Priming and Alcohol Taste Cues Is Associated With DRD4 VNTR and OPRM1 Genotypes

(2008) Francesca M. Filbey et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

Invited Commentary: Efficient Testing of Gene-Environment Interaction

(2008) N. Chatterjee et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Variants in Nicotinic Receptors and Risk for Nicotine Dependence

(2008) Laura Jean Bierut et al.   AMERICAN JOURNAL OF PSYCHIATRY

Genetic variability in nicotinic acetylcholine receptors and nicotine addiction: Converging evidence from human and animal research

(2008) George S. Portugal et al.   BEHAVIOURAL BRAIN RESEARCH

Synergistic effects of the dopaminergic and glutamatergic system on hippocampal volume in alcohol-dependent patients

(2008) I. Puls et al.   BIOLOGICAL PSYCHOLOGY

Molecular Genetics of Alcohol Dependence and Related Endophenotypes

(2008) Yann Strat et al.   CURRENT GENOMICS

Nicotine modulates expression of miR-140*, which targets the 3′-untranslated region of dynamin 1 gene (Dnm1)

(2008) Weihua Huang et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

How to Interpret a Genome-wide Association Study

(2008) Thomas A. Pearson   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Brain Chromatin Remodeling: A Novel Mechanism of Alcoholism

(2008) S. C. Pandey et al.   JOURNAL OF NEUROSCIENCE

Detection of Genetic Association and a Functional Polymorphism of Dynamin 1 Gene with Nicotine Dependence in European and African Americans

(2008) Qing Xu et al.   NEUROPSYCHOPHARMACOLOGY

Increased OPRM1 DNA Methylation in Lymphocytes of Methadone-Maintained Former Heroin Addicts

(2008) David A Nielsen et al.   NEUROPSYCHOPHARMACOLOGY

A cost-effectiveness analysis of genetic testing of the DRD2 Taq1A polymorphism to aid treatment choice for smoking cessation

(2008) Nicky Welton et al.   NICOTINE & TOBACCO RESEARCH

Cost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatment

(2008) D F Heitjan et al.   PHARMACOGENOMICS JOURNAL

Epigenetic mechanisms in drug addiction

(2008) William Renthal et al.   TRENDS IN MOLECULAR MEDICINE

Pharmacogenetic Treatments for Drug Addiction: Alcohol and Opiates

(2008) Colin N. Haile et al.   AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE